Luxempart, a Luxembourg-based investment and private equity company, on Wednesday said it has acquired a 8.4 percent stake in Nexus AG, a German-based publicly listed hospital software provider in Europe through a capital increase of 72.5 million euro.
Luxempart will become a new anchor shareholder of the company, supporting its management team to continue their successful growth path. This transaction complements well with Luxempart’s new investment strategy to have focused, large investments in market leading companies where Luxempart can be an active owner.
Nexus AG develops and sells software solutions for the European healthcare market. The product range covers core hospital information systems (HIS) and a wide range of diagnostic software solutions serving almost all functional requirements of hospitals, psychiatric institutions, rehabilitation facilities and diagnostic centres.
Consistent double-digit sales growth
With sales of approximately EUR 188 million in 2021, Nexus is listed and headquartered in Germany and employs approximately 1,650 people with a presence in seven European countries. The company has achieved a strong profitable growth track record over the last 20 years with a compounded annual growth rates for sales at 16 percent driven by a mix of organic growth and continuous bolt-on acquisitions.
“Luxempart is excited to support Nexus and its management team in the next growth phase,” said the firm’s managing director John Penning in a statement. “Nexus is the perfect example of companies in which Luxempart wants to invest under its new strategy: a sizeable investment ticket above 50 million euro, an active role as an anchor shareholder and a trusted partnership based on clear governance principles.”